Condition

Pulmonary Infections (2)

Pseudomonas Aeruginosa (1)

Pseudomonas Aeruginosa in Cystic Fibrosis (1)

Overall Status

Completed (2)

Sign in for free

Phase

phase 3 (1)

phase 4 (1)

Sponsor

Novartis Pharmaceuticals (2)

Collaborator

Intervention

tbm100 (1)

tobramycin inhalation powder (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

pulmonary infections

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Pulmonary Infections, Pseudomonas Aeruginosa Trial in Worldwide (Tobramycin inhalation powder)

Completed

Pulmonary Infections
Pseudomonas Aeruginosa

Tobramycin inhalation powder

Pleven, Bulgaria
+16 more

May 6, 2021

Pulmonary Infections, Pseudomonas Aeruginosa in Cystic Fibrosis Trial in Worldwide (TBM100)

Completed

Pulmonary Infections
Pseudomonas Aeruginosa in Cystic Fibrosis

TBM100

Little Rock, Arkansas
+48 more

Feb 8, 2015